The Association for the Accreditation of Human Research Protection Programs, Inc. announced that it has accredited another seven organizations—including its first organizations in India.
Four of the seven newly accredited organizations are outside the United States, underscoring AAHRPP's progress in moving toward one standard worldwide for protecting research participants. All told, 241 organizations have now earned accreditation, including institutions in 45 states, the District of Columbia, Puerto Rico, Canada, China, India, Korea, and Singapore.
The latest accreditations come as AAHRPP celebrates the 10th anniversary of its founding in 2001 and prepares to mark 10 years since the issuance of the first accreditation standards in 2002.
"The goal, a decade ago, was to establish an accrediting organization to strengthen research protections and improve the quality of research," said Marjorie A. Speers, PhD, AAHRPP President and CEO. "Since then, hundreds of organizations have earned the AAHRPP gold seal, demonstrating their commitment to rigorous standards that help protect research participants while ensuring that society continues to reap the benefits of research."
The newly accredited organizations are:
Creighton University, Omaha, Nebraska, USA
Diex Research Sherbrooke, Inc. & Diex Research Montreal, Inc., Sherbrooke, Quebec, Canada
IRB Services, Aurora, Ontario, Canada
Kasturba Hospital, Manipal, Manipal, India
Manipal Hospital Bangalore, Bangalore, India
Texas Health Resources, Arlington, Texas, USA
The University of Alabama, Tuscaloosa, Alabama, USA
For these and all accredited organizations, AAHRPP accreditation translates into significant benefits for research participants and society as a whole.
Accreditation is available to United States and international organizations that conduct biomedical, behavioral or social sciences research involving human participants. The list of accredited organizations includes community and teaching hospitals; VA facilities, universities; institutional review boards; research institutes; and contract research organizations.
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Managing Side Effects and Dosing in Off-Label GLP-1 Use with Help from Real-World Evidence
July 18th 2025Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, explains how real-world data is helping researchers navigate gastrointestinal side effects, dose flexibility, and long-term tolerability in off-label GLP-1 use.
Anselamimab Misses Primary Endpoint in Phase III CARES Trials for AL Amyloidosis
July 17th 2025In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a prespecified subgroup analysis revealed meaningful improvements in survival and cardiovascular outcomes.